scorecardresearch
Add as a preferred source on Google
Friday, March 13, 2026
TopicBharat Biotech

Topic: Bharat Biotech

After filing for Covaxin patent solo, Bharat Biotech to add ICMR as co-inventor

Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.

Several immunisation drives hit, Union govt prods Bharat Biotech over ‘delay’ in vaccine supplies

Health ministry points at shortfall in supply of 3 vaccines, for Japanese Encephalitis, Hepatitis B & rotavirus. It also sought reason for delay in letter to Bharat Biotech.

World’s 1st Covid nasal vaccine by Bharat Biotech to launch on R-Day, says founder Krishna Ella

Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.

Bharat Biotech’s booster nasal vaccine on CoWIN from today as India strengthens Covid response

Official sources clarifeid that masks were not mandatory yet. Congress’s Bharat Jodo Yatra can also continue provided it adhered to Covid protocols, they said.

‘Fake news’ — Bharat Biotech, govt deny report on ‘discrepancies’ in Covaxin trial data

Medical news site STAT had cited internal documents to allege that Bharat Biotech had taken ‘questionable’ steps under political pressure to speed up development of Covaxin.

Drug authority clears use of India’s first nasal Covid-19 vaccine made by Bharat Biotech

The Covaxin maker’s nasal shot will be used in emergency situations for the 18+ age group, Union Health Minister Mansukh Mandaviya tweeted.

WHO move to suspend Covaxin’s UN supply won’t affect trips to UK, US & over 90 nations, govt says

Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

ICMR received Rs 171.74 cr in royalty from sale of Covaxin till 31 Jan, govt tells Rajya Sabha

ICMR and Bharat Biotech developed Covaxin together, and MoS Health Bharati Pawar says in written reply that the research body spent Rs 35 crore on its development.

Covaxin booster increases antibody levels by 19-97 fold against Covid variants: Phase 2 results

Study, which is yet to be peer-reviewed, was published on preprint portal medRxiv Saturday. It was conducted by Bharat Biotech and ICMR, which co-developed the vaccine.

On Camera

Period pain is real. Blanket menstrual leave policy isn’t a fix

The Supreme Court is right to point out the 'mindset of employers', who, because of this policy, may deduce that 'women are inferior.'

A war in the Gulf, a crisis in Gujarat’s Morbi: India’s ceramics capital counts the cost

Morbi makes 80-90% of India’s ceramic exports. The West Asia conflict has cut its propane supply, shutting 200 factories and threatening 400 more—along with 9 lakh livelihoods.

Supreme Leader Mojtaba, the man Iran must keep alive & the secret force ‘tasked with it’—all about NOPO

The Nirouyeh Vijeh Pasdaran Velayat, or NOPO, was the only force Ali Khamenei trusted.It was founded in 1991 and is more feared than the Revolutionary Guards.

Trump brings the Age of Humiliation for friends. Modi needs stoicism abroad, humility at home

Trump has ushered in the age of humiliation. His method is to push around America’s friends rudely and publicly. He knows none of them can afford to fight back.